11/14/2024
4:25 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:17 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form DEF 14A | |
10/28/2024
3:18 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form ARS | |
10/17/2024
3:32 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form PRE 14A | |
09/17/2024
4:21 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:01 PM | Narayan Prabhu (Reporting)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
Reviva Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:01 PM | Bhat Laxminarayan (Reporting)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
Reviva Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/22/2024
4:04 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K/A | |
08/22/2024
8:28 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 424B5 | |
08/21/2024
4:16 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:10 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:15 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024
8:01 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
8:30 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject)
Reviva Pharmaceuticals (Subject)
VEDANTA PARTNERS, LLC (Filed by)
| Form SC 13D/A | |
05/29/2024
6:00 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
3:31 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/15/2024
7:10 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:12 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:13 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
4:01 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
7:20 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
7:22 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
6:45 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:00 AM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form NT 10-K | |
02/16/2024
3:32 PM | Bhat Laxminarayan (Filed by)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject)
Reviva Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/02/2024
3:38 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
Reviva Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/22/2023
5:28 PM | REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
Reviva Pharmaceuticals (Issuer)
SAXENA PARAG (Reporting)
VEDANTA ASSOCIATES, L.P. (Reporting)
VEDANTA PARTNERS, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
